-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of November 4, the General Department of the State Medical Products Administration publicly solicited opinions on the "Announcement on the Implementation of Electronic Declaration of Drug Registration Applications (Draft for Comments)", which mentioned that from December 1, 2022, the drug registration applications reviewed and approved by the NMPA and the supplementary materials in the review process will be adjusted to be submitted
in electronic form.
From the date of the announcement, if it is submitted in eCTD format, there is no need to submit paper materials
.
With this, the full e era has arrived!
Attachment download link: